https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 In utero smoking exposure induces changes to lung clearance index and modifies risk of wheeze in infants https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55734  6 ppm. Lung function data from healthy infants (age 5–9 weeks) born to asthmatic mothers and parent-reported respiratory questionnaire data aged 12 months were collected in the Breathing for Life Trial (BLT) birth cohort. Tidal breathing analysis and SF6-based Multiple Breath Washout testing were performed in quiet sleep. Descriptive statistics and regression analysis were used to assess associations. Results: Data were collected on 423 participants. Infants born to women who self-reported smoking during pregnancy (n = 42) had higher lung clearance index (LCI) than those born to nonsmoking mothers (7.90 vs. 7.64; p = .030). Adjusted regression analyzes revealed interactions between self-reported smoking and LCI (RR: 1.98, 95% CI: 1.07–3.63, 0.028, for each unit increase in LCI) and between eCO > 6 ppm and LCI (RR: 2.25, 95% CI: 1.13–4.50, 0.022) for the risk of wheeze in the first year of life. Conclusion: In utero tobacco smoke exposure induces lung ventilation inhomogeneities. Furthermore, an interaction between smoke exposure and lung ventilation inhomogeneities increases the risk of having a wheeze in the first year of life.]]> Wed 19 Jun 2024 09:54:57 AEST ]]> Maternal asthma is associated with reduced lung function in male infants in a combined analysis of the BLT and BILD cohorts https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46724 Tue 29 Nov 2022 11:27:33 AEDT ]]> Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47636 Tue 24 Jan 2023 14:30:31 AEDT ]]> Bronchiolitis hospital admission in infancy is associated with later preschool ventilation inhomogeneity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54571 Tue 14 May 2024 14:15:56 AEST ]]> Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48952 Tue 02 May 2023 11:43:55 AEST ]]> Accumulation mode particles and LPS exposure induce TLR-4 dependent and independent inflammatory responses in the lung https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34994 Thu 28 Oct 2021 13:04:29 AEDT ]]> Cord blood group 2 innate lymphoid cells are associated with lung function at 6 weeks of age https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40658 Thu 28 Jul 2022 12:42:40 AEST ]]> Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45652 Thu 23 Mar 2023 13:58:11 AEDT ]]> Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22279 Sat 24 Mar 2018 07:17:42 AEDT ]]> After asthma: redefining airways diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43034 Mon 12 Sep 2022 11:49:26 AEST ]]> Rhinovirus bronchiolitis, maternal asthma, and the development of asthma and lung function impairments https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41043 p=.001), use of inhaled corticosteroids (68.2% and RR 2.17, 95% CI 1.19-3.99, p=.001) and short-acting β-agonists in the last 12 months (95.2% and RR 1.49, 95% CI 1.17-1.89, p=.001), as compared to those with RV negative bronchiolitis and no maternal asthma history. More children in this group had an abnormal airway resistance (33.3% and adjusted risk ratio [aRR] 3.11, 95% CI 1.03-9.47, p=.045) and reactance (27.8% and aRR 2.11, 95% CI 1.06-4.26, p=.035) at 5 Hz, as compared to those with RV negative bronchiolitis and no maternal asthma history. Conclusion: Hospitalization for RV positive bronchiolitis in early life combined with a history of maternal asthma identifies a subgroup of children with a high asthma burden while participants with only one of the two risk factors had intermediate risk for asthma.]]> Mon 08 Aug 2022 14:50:18 AEST ]]> Maternal asthma, breastfeeding, and respiratory outcomes in the first year of life https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40099 χ2 tests and logistic regression models, adjusting for confounders, were utilized. Data were complete for 605 participants at T1 and 486 (80%) at T2. Of 605 participants: 89% initiated breastfeeding and 38% breastfed for more than 6 months. Breastfeeding for more than 6 months vs “never” was associated with a reduced adjusted relative risk of infant wheeze at T1 (0.54, 95% confidence interval, 0.30‐0.96). Bronchiolitis risk was reduced at T1 and T2 with more than 6 months of breastfeeding vs “never.” Breastfeeding duration of 1 to 3 months, 4 to 6 months, and more than 6 months were associated with a reduced risk of infant healthcare utilization (all P < .05, vs “never”), but not medication use (P > .05). Breastfeeding for more than 6 months was associated with a reduced risk of wheeze, bronchiolitis, and wheeze‐related healthcare utilization in infants at risk due to maternal asthma. Notably, breastfeeding for shorter durations was associated with a reduced risk of healthcare utilization compared with none. Larger cohorts are needed to further examine the impact of breastfeeding exposure on respiratory health in infants exposed to maternal asthma.]]> Mon 06 May 2024 11:07:39 AEST ]]>